Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma

Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma

(2013) Catarina Alisa Liebscher et al.   HUMAN PATHOLOGY

The Stem-Cell Profile of Ovarian Surface Epithelium is Reproduced in the Oviductal Fimbriae, with Increased Stem-Cell Marker Density in Distal Parts of the Fimbriae

(2013) Nelly Auersperg   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche

(2013) Andrea Flesken-Nikitin et al.   NATURE

ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome

(2012) Yu-Chi Wang et al.   AMERICAN JOURNAL OF PATHOLOGY

Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step

(2012) Michael Herman Chui   INTERNATIONAL JOURNAL OF CANCER

Validation of an Algorithm for the Diagnosis of Serous Tubal Intraepithelial Carcinoma

(2012) Russell Vang et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Diagnosis of Serous Tubal Intraepithelial Carcinoma Based on Morphologic and Immunohistochemical Features

(2011) Kala Visvanathan et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance

(2011) David Tarin   CANCER AND METASTASIS REVIEWS

ALDH1A1 Is a Novel EZH2 Target Gene in Epithelial Ovarian Cancer Identified by Genome-Wide Approaches

(2011) H. Li et al.   Cancer Prevention Research

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm

(2011) Robert J. Kurman et al.   HUMAN PATHOLOGY

Cells of origin in cancer

(2011) Jane E. Visvader   NATURE

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells

(2011) Rebecka Hellsten et al.   PLoS One

Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells

(2011) J. M. Stewart et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase

(2010) Matthew R. Clay et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

The Origin of Ovarian Carcinomas

(2010) Nelly Auersperg   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

The Fallopian Tube-Peritoneal Junction

(2010) Jeffrey D. Seidman et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer

(2010) C. N. Landen et al.   MOLECULAR CANCER THERAPEUTICS

Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers

(2010) Shan Deng et al.   PLoS One

A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development

(2009) A. Jimeno et al.   MOLECULAR CANCER THERAPEUTICS

Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations

(2008) S. Ma et al.   MOLECULAR CANCER RESEARCH

ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells

(2008) Julie Douville et al.   STEM CELLS AND DEVELOPMENT